Metalloproteinases, extracellular matrix and cancer;Metaloproteinasas, matriz extracelular y cáncer

Anales de la Real Academia Nacional de Farmacia

Volumn 76, Issue 1, 2010, Pages 59-84

  Angosto, María Cascales ^a   Álvarez Gómez, Juan Ángel ^a  

^a NONE

Author keywords

Anti cancer therapy; Cancer; Extracellular matrix; Metalloproteinases; Metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; CGS 27023; CGS 27023A; CHEMOKINE; CYTOKINE; GROWTH FACTOR; MARIMASTAT; MATRIX METALLOPROTEINASE INHIBITOR; METALLOPROTEINASE; N1 [2,2 DIMETHYL 1 [(METHYLAMINO)CARBONYL]PROPYL] N4 HYDROXY 2 (2 METHYLPROPYL)BUTANEDIAMIDE; PRINOMASTAT; PROTEINASE; REBIMASTAT; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; CANCER INVASION; CARCINOGENESIS; EXTRACELLULAR MATRIX; METASTASIS; NEOPLASM; PROTEIN DEGRADATION; REVIEW; TUMOR GROWTH;

EID: 77953114281     PISSN: None     EISSN: 1697428X     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Cascales Angosto, M. (2008) Matriz extracelular y proteasas. En: Bases celulares y moleculares de la regeneración hepática (autora Cascales, M.). Instituto de España. Madrid, pp. 71-108.
2. Boticario Boticario, C. & Cascales Angosto, M. (2008) Metaloproteinasas de la matriz extracelular y cancer. En: Innovaciones en cáncer (autoras Boticario, C. & Cascales, M.). UNED. Madrid, pp. 415-439.
3. Yan, C. & Boyd, D. D. (2007) Metalloproteinase gene expression. J. Cell Physiol. 211: 19-26.
4. Roycik, M. D.; Fang, X. & Sang, O. X. (2009) A fresh prospect of extracellular hydrolytic enzymes and their substrates. Curr. Pharm. Des. 15: 1295-1308.
5. Murphy, G. & Nagase, H. (2008) Progress in matrix metalloproteinase research. Mol. Aspects Med. 29: 290-308.
6. Gross, J. & Lapiere, C. M. (1962) Collagenolytic activity in amphibian tisues: a tissue culture assay. Proc. Natl. Acad. Sci. USA. 45: 1014-1022.
7. Bauer, E. A.; Stricklin, G. F.; Jeffrey, J. J. & Eisen, A. Z. (1975) Collagenase production by human skin fibroblasts. Biochem. Biophys. Res. Commun. 64: 232-240.
8. Sternlicht, M. D. & Werb, Z. (2001) How matrix metalloproteinases regulate cell behabior. Annu. Rev. Cell Dev. Biol. 17: 463-516.
9. Harper, E. & Bloch, K. J. (1971) The zymogen of tadpole collagenase. Biochemistry. 10: 3055-13041
10. Fingleton, B. (2007) Matrix metalloproteinases as valid clinical targets. Curr. Pharm. Des. 13: 333-346.
11. Overall, C. M. & López-Otín, C. (2002) Strategies for MMP inhibition in cancer: Innovations for the post-trial era. Nature Rev. Cancer. 2: 657-672.
12. Folgueras, A. R.; Pendas, A. M.; Sánchez, L. M. & López-Otín, C. (2004) Metalloproteinases in cancer: from new function to improved inhibition strategies. Int. J. Dev. Biol. 48: 411-424.
13. Liotta, L. A.; Tryggvason, K.; Garbosa, S., Hart, I. et al. (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 284: 67-68.
14. Deruyina, E. & Quigley, J. (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25: 9-34.
15. Mochizuki, S. & Okada, Y. (2007) ADAMs in cancer cell proliferation and progression. Cancer Sci. 98: 621-628. (Pubitemid 46563436)
16. Edwards, D. R.; Handsley, M. M. & Pennington, C. J. (2008) The ADAM metalloproteinases. Mol. Aspects Med. 29: 258-289.
17. Steiner, D. F. (1998) The proprotein convertases. Curr. Opin. Chem. Biol. 2: 31-39.
18. López-Otín, C. & Bond, J. S. (2008) Proteases: multifunctional enzymes in life and disease. J. Biol. Chem. 283: 31433-31437.
19. López-Otín, C. & Matrisian, L. (2007) Emerging roles of proteases in tumor progression. Nature Rev. Cancer. 7: 800-808.
20. Huang, S. C.; Sheu, B. C.; Chang, W. C.; Chaeg, C. Y.; Wang, P. H. & Lin, S. (2009) Extracellular matrix proteases - Cytokine regulation role in cancer and pregnancy. Front. Biosci. 14: 1571-1588.
21. Puente, X. S.; Sánchez, L. M.; Gutiérrez-Fernández, A.; Velasco, G. & Lòpez-Otìn, C. (2005) A genomic view of the complexity of mammalian proteolytic systems. Biochem. Soc. Trans. 33: 331-334.
22. Nakamoto, T.; Yamagata, T., Sakai, T., et al. (2000) CIZ, a zinc finger protein that interacts with p130(cas) and activates the expression of matrix metalloproteinases. Mol. Cell Biol. 20: 1649-1658.
23. Ye, S. (2000) Polymorphisms in matrix metalloproteinase gene promoters: implications in regulation of gene expression and susceptibility of various diseases. Matrix Biol 19: 623-629.
24. Lòpez-Otìn, C. & Overall, C. M. (2002) Protease degradomics a new challenge for proteomics. Nat. Rev. Mol. Cell Biol. 3: 509-519.
25. Coussens, L. M.; Fingleton, B. & Matrisian, L. M. (2002) Matrix metalloprotease inhibitors and cancer: trials and tribulations. Science. 295: 2387-2392. (Pubitemid 34270240)
26. Fingleton, B. (2003) Matriz metalloproteinases inhibitors for cancer therapy: the current situation and future prospects. Expert Opin. Ther. Targets. 7: 385-397.
27. Handsley, M. M. & Edwards, D. R. (2005) Metalloproteinases and their inhibitors in tumor angiogenesis. Int. J. Cancer. 115: 849-860.
28. Fridman, R. (2006) Metalloproteinases and cancer. Cancer Metastasis Rev. 25: 7-8.
29. Hanahan, D. & Weinberg, R. (2000) The hallmark of cancer. Cell. 100: 57-70.
30. Bergers, G. & Benjamin, L. E. (2003) Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer. 3: 401-410.
31. Fanjul-Fernández, M.; Folgueras, A. R.; Cabrera, S. & López-Otín, C. (2009) Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models. Biochim. Biophys. Acta. Jul 23. [Epub ahead of print].
32. Gutiérrez-Fernández, A.; Fueyo, A.; Folgueras, A. R. & López-Otín, C. (2008) Matrix Metalloproteinase-8 Functions as a Metastasis Suppressor through Modulation of Tumor Cell Adhesion and Invasion. Cancer Res. 68: 2755-2763.
33. Gueders, M. M.; Balbin, M.; Rocks, N.; Foidart, J. M. et al. (2005) Matrix metalloproteinase-8 deficiency promotes granulocyte allergen-induced airway inflammation. J. Immunol. 175: 2589-2597.
34. Affara, N. I.; Andreu, P. & Coussens, L. M. (2009) Delineating protease functions during cancer development. Methods Mol. Bio. 539: 1-32.